How should I manage a patient with absent left vertebral artery flow on carotid imaging?

Management of Absent Left Vertebral Artery Flow

In a patient with absent left vertebral artery flow on carotid imaging, immediately obtain confirmatory vascular imaging with CTA or MRA to distinguish between vertebral artery hypoplasia, stenosis, occlusion, or dissection, then initiate medical therapy with aspirin 75-325 mg daily and aggressive atherosclerotic risk factor modification regardless of symptoms.1

Initial Diagnostic Approach

The absence of vertebral artery flow on carotid imaging requires immediate clarification of the underlying pathology:

• Obtain CTA or MRA (not ultrasound alone) to definitively characterize the vertebral artery anatomy 1, 2, 3
• Distinguish between:
  • Congenital hypoplasia (patent but small vessel) 4
  • Atherosclerotic stenosis or occlusion 1
  • Vertebral artery dissection (particularly if any neurological symptoms present) 4
  • Subclavian steal phenomenon (retrograde flow) 5, 6

Critical caveat: In atraumatic patients without acute neurological symptoms, an absent vertebral artery flow void has low likelihood of altering management - 40% of such cases show hypoplastic but patent vessels on follow-up imaging 4. However, you must still rule out acute pathology.

Symptom Assessment

Determine if the patient has:

Posterior circulation symptoms:

• Dizziness, vertigo, diplopia
• Perioral numbness, blurred vision, tinnitus
• Ataxia, bilateral sensory deficits, syncope
• Prior posterior circulation TIA or stroke 1, 7

High-risk anatomic features requiring vertebral imaging:

• Bilateral carotid occlusions 1, 3
• Unilateral carotid occlusion with incomplete circle of Willis 1, 3
• Subclavian steal syndrome 1

Medical Management (Class I Recommendations)

All patients with vertebral artery disease require:

1. Antiplatelet therapy: Aspirin 75-325 mg daily (or 81-325 mg daily if symptomatic with stroke/TIA) 1

   • If aspirin contraindicated: clopidogrel 75 mg daily or ticlopidine 250 mg twice daily 7

2. Aggressive atherosclerotic risk factor modification following the same standards as carotid atherosclerosis 1, 2, 1:

   • Blood pressure control
   • Statin therapy
   • Diabetes management
   • Smoking cessation
   • Lifestyle modifications

Surveillance Strategy

For symptomatic patients:

• Serial noninvasive imaging (CTA or MRA) is reasonable to assess disease progression and exclude new lesions 1, 3
• Consider catheter-based angiography if revascularization is being considered and noninvasive imaging fails to define stenosis location/severity 1, 2

For asymptomatic patients:

• Clinical follow-up is generally sufficient 4
• In one study of 54 patients with incidentally discovered absent vertebral artery flow void, 32 remained asymptomatic throughout follow-up without intervention 4

When to Consider Revascularization

Revascularization is not routinely recommended for asymptomatic vertebral artery disease. However, intervention may be reasonable for:

Symptomatic posterior circulation ischemia despite optimal medical therapy with:

• Documented vertebral artery stenosis/occlusion
• Recurrent symptoms refractory to antiplatelet therapy
• Subclavian steal syndrome causing disabling symptoms 1

Important distinction: Only 5.8% of patients with subclavian steal detected on duplex required intervention for disabling posterior circulation symptoms 6. Most patients with vertebral artery flow abnormalities remain asymptomatic and do not require intervention.

Key Clinical Pitfalls

1. Don't assume absent flow equals occlusion - may be hypoplastic but patent vessel 4
2. Don't intervene on asymptomatic findings - natural history is benign in most cases 4, 6
3. Don't miss concomitant carotid disease - 63% of patients with subclavian steal have >50% carotid stenosis 6
4. Don't overlook dissection in symptomatic patients - requires immediate recognition and different management 4
5. Completely reversed flow doesn't always mean subclavian steal - can indicate proximal vertebral artery occlusion 8